Does Amiodarone Cause Weight Gain? What to Know

Amiodarone is not listed as a drug that directly promotes fat gain the way corticosteroids or certain antipsychotics do, but it frequently reshapes thyroid function in ways that can tip the scale upward. Roughly 15 to 20 percent of people taking amiodarone develop some form of thyroid dysfunction, and when that dysfunction takes the form of an underactive thyroid, weight gain is one of the classic downstream symptoms. The relationship is indirect but common enough that anyone on amiodarone who notices the number on the scale creeping up should consider the thyroid as a likely culprit.

How Amiodarone Interferes With Thyroid Hormones

Amiodarone is loaded with iodine. Each 200 mg tablet delivers roughly 75 mg of organic iodine, and about 10 percent of that is released as free iodine in the body. That is many times higher than the typical daily dietary intake. This iodine flood has direct consequences for the thyroid gland, but the drug also affects how thyroid hormones are processed in the rest of the body. Amiodarone inhibits an enzyme responsible for converting the storage form of thyroid hormone (T4) into its more active form (T3). The result is a rise in circulating T4 and a drop in T3, which shifts the body’s metabolic thermostat in a direction that can slow calorie burning, increase fluid retention, and promote gradual weight gain.¹

In many patients, the thyroid eventually adapts and hormone levels normalize within a few months. But in a sizable minority, the gland cannot compensate, and a genuine hypothyroid state sets in. This is called amiodarone-induced hypothyroidism (AIH), and it carries the full metabolic slowdown you would expect from an underactive thyroid: fatigue, cold intolerance, constipation, dry skin, and yes, weight gain. The weight gain in AIH is typically moderate, on the order of a few kilograms, and is a mix of true fat accumulation and fluid retention that comes with sluggish metabolism.

Why 15 to 20 Percent of Patients Are Affected

The thyroid dysfunction rate is not trivial. Studies consistently place it between 15 and 20 percent of patients treated with amiodarone, though the split between hypothyroidism and the opposite problem, thyrotoxicosis, varies by geography. In iodine-sufficient regions like the United States and the United Kingdom, hypothyroidism is the more common outcome. In iodine-deficient areas, particularly parts of Southern Europe, thyrotoxicosis (an overactive thyroid) tends to predominate.²

Who develops AIH depends on several risk factors. Women are more susceptible, as are people who already have positive thyroid antibodies or a family history of autoimmune thyroid disease. Pre-existing subclinical hypothyroidism, which may have been silent before the drug, can become overt once amiodarone’s iodine load tips the balance. The takeaway is that some people walk into amiodarone therapy with a thyroid that is already borderline vulnerable, and the drug pushes it over the edge.

Fluid Retention and Heart Failure Overlap

Weight gain on amiodarone gets complicated because most people taking the drug have a serious heart rhythm disorder, and many also have underlying heart failure. Heart failure itself causes fluid retention, and some of the weight people attribute to amiodarone may actually reflect worsening fluid balance from the cardiac condition. Distinguishing between thyroid-driven weight gain and heart-failure-driven fluid overload matters because the treatments are different. Thyroid-driven weight gain responds to thyroid hormone replacement, while fluid overload calls for adjustments to diuretics and heart failure medications.

A practical clue is the tempo of the change. Fluid retention from heart failure tends to appear over days to a couple of weeks, often with swollen ankles and shortness of breath. Thyroid-mediated weight gain is slower, accumulating over weeks to months, and comes alongside the other symptoms of hypothyroidism like fatigue and cold sensitivity. If you are gaining weight on amiodarone and feel genuinely more tired or sluggish, a thyroid blood test is a straightforward first step.

The Drug Stores Itself in Fat Tissue

One of the most unusual things about amiodarone is its extreme fat solubility. After chronic oral dosing, the drug and its active breakdown product (desethylamiodarone) accumulate heavily in adipose tissue, far more than in other organs like the kidney or brain.³ This fat reservoir is what gives amiodarone its famously long half-life, often quoted at 40 to 55 days. Even after you stop taking the drug, meaningful levels persist in fat stores for months.

This storage pattern has a practical consequence for weight. The drug is, in a literal sense, sitting in your fat tissue and continuing to exert its thyroid-disrupting effects long after the last pill. It also means that rapid weight loss can paradoxically release a bolus of stored amiodarone back into the bloodstream, which has been documented to trigger delayed thyroid toxicity (more on that below). People who have been on amiodarone for years carry a substantial pharmacological reservoir in their body fat.

What Amiodarone Does to the Liver and Fat Metabolism

Beyond its thyroid effects, amiodarone has a direct impact on how the liver handles fat. Laboratory research has shown that the drug reduces the production of new fat (lipogenesis) in adipose tissue while simultaneously increasing the breakdown of stored fat (lipolysis). That might sound like it would cause weight loss, but the freed fatty acids do not simply disappear. They flood the liver, where the drug also ramps up genes involved in fatty acid uptake and transport. The end result is an accumulation of free fatty acids in liver cells, which contributes to a form of drug-induced fatty liver disease.⁴

Separate cell culture experiments have confirmed that repeated amiodarone exposure can induce steatosis, which is the buildup of fat droplets inside liver cells, along with increased expression of fat-producing genes in the liver itself.⁵ Additional studies in liver tissue slices show that amiodarone activates pathways related to fat synthesis and fatty acid oxidation simultaneously, creating a metabolically confused state where the liver both makes more fat and tries to burn more fat at the same time.⁶

These hepatic changes do not directly put pounds on you. But drug-induced fatty liver can impair how well the organ manages cholesterol, triglycerides, and blood sugar over time, all of which feed into metabolic health and can make it harder to maintain a stable weight. If blood tests show elevated liver enzymes while you are on amiodarone, fatty liver is one of the things your doctor will be thinking about.

When Weight Loss Triggers a Delayed Thyroid Problem

Here is a counterintuitive twist. Because amiodarone stockpiles in fat tissue, losing a significant amount of weight can actually cause a delayed surge of the drug back into circulation. A case report documented a patient who developed type 2 amiodarone-induced thyrotoxicosis months after stopping the drug, precipitated by substantial weight loss that shrank the fat stores where amiodarone had been parked. The weight loss changed the volume of distribution, effectively re-dosing the patient with their own stored drug and triggering an overactive thyroid.⁷

This matters for patients who are prescribed GLP-1 agonists like semaglutide for weight management while also having a history of amiodarone use. The rapid fat loss that these newer weight loss drugs can produce may inadvertently liberate stored amiodarone. Clinicians are only beginning to recognize this interaction, and it is a good example of why anyone who has taken amiodarone, even in the past, should keep their doctors informed about it. The drug’s shadow extends well beyond the date it was stopped.

Monitoring Your Thyroid on Amiodarone

Guidelines recommend checking thyroid function before starting amiodarone and then every six months for the entire time you are on it, and even for a period after stopping. In practice, adherence to this schedule is inconsistent. One study found that while 97 percent of patients had thyroid function tested before initiating amiodarone, only 59 percent were being monitored at the recommended six-month intervals afterward.⁸

That gap matters. If hypothyroidism develops slowly and nobody checks, a patient might spend months feeling progressively more tired and gaining weight without understanding why. By the time someone connects the dots, the weight gain and metabolic slowdown may have compounded other health issues. If you are on amiodarone and your doctor has not checked your thyroid in the last six months, it is entirely reasonable to ask for a blood draw. The test is a simple TSH level, sometimes with free T4 added, and it is inexpensive.

Treating Thyroid Problems Without Stopping Amiodarone

One piece of reassuring news is that developing hypothyroidism on amiodarone does not necessarily mean you have to stop the drug. For many patients, especially those whose heart rhythm disorder has no good alternative treatment, the standard approach is to add levothyroxine, a synthetic thyroid hormone, to compensate for what the gland is no longer producing on its own.² The levothyroxine dose is adjusted based on blood tests until thyroid levels normalize, and with them, the fatigue, cold intolerance, and weight gain typically improve.

Managing thyrotoxicosis (the overactive thyroid scenario) is more complex and sometimes does require stopping amiodarone, along with specific drug therapy to rein in the overactive gland. The distinction between the two types of thyroid dysfunction is critical and usually requires an endocrinologist’s input. The good news is that with proper monitoring, either problem can be caught early enough to be managed before it causes significant metabolic disruption.

How Dronedarone Compares

Dronedarone was developed as a structural relative of amiodarone that lacks the iodine atoms thought to be responsible for much of the thyroid toxicity. Interestingly, research on dronedarone found that it actually prevented body weight gain in experimental settings, apparently by suppressing food intake. The drug appeared to mimic some aspects of hypothyroidism selectively in the heart without inducing systemic thyroid dysfunction or the metabolic slowdown that leads to weight gain.⁹

Dronedarone is not a perfect substitute, though. It is less effective than amiodarone for rhythm control, particularly in persistent atrial fibrillation, and it carries its own set of warnings, including a restriction against use in patients with advanced heart failure. For patients whose primary concern is thyroid-related weight gain on amiodarone, dronedarone is worth discussing with a cardiologist, but the trade-off between efficacy and side effect profile has to be weighed carefully on an individual basis.

Practical Steps if You Are Gaining Weight on Amiodarone

If you notice weight creeping up after starting amiodarone, the first and most important step is a thyroid function test. A rising TSH level with a low free T4 confirms hypothyroidism, and treatment with levothyroxine can reverse the metabolic slowdown. If thyroid levels come back normal, the weight gain is less likely to be amiodarone’s fault directly, and other common culprits like fluid retention from heart failure, reduced physical activity due to the underlying cardiac condition, or dietary changes should be explored.

Keep in mind that amiodarone is rarely prescribed casually. The people taking it generally have arrhythmias that are dangerous enough to justify a drug with a long list of potential side effects. Stopping the drug because of modest weight gain, without a cardiologist’s guidance, is risky. The better path is to identify the mechanism, treat the thyroid if it is the issue, and monitor liver enzymes and thyroid levels on the recommended schedule. Weight gain on amiodarone is manageable; uncontrolled atrial fibrillation or ventricular tachycardia is not.

Why Amiodarone’s Side Effects Linger After Discontinuation

The drug’s extreme fat solubility creates a pharmacological afterlife that few other medications share. Because amiodarone and its metabolites accumulate disproportionately in adipose tissue compared to other organs, the effective half-life in a person who has taken the drug for months or years can stretch well beyond the commonly cited 40 to 55 days.³ Some patients continue to show detectable drug levels for six months or more after their final dose. This means that thyroid dysfunction, including the kind that causes weight gain, can emerge or persist long after the prescription bottle has been retired.

Doctors who are aware of this long tail will continue thyroid monitoring for at least six to twelve months after amiodarone is stopped. Patients who change physicians or fall through the cracks of follow-up care during that window may not realize that a new thyroid problem is connected to a drug they stopped taking months ago. If you have ever been on amiodarone and develop unexplained fatigue, weight changes, or heat and cold sensitivity, mentioning the drug history to your current doctor is worth doing even if it feels like ancient history.